A detailed history of Sound Income Strategies, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Sound Income Strategies, LLC holds 468 shares of VRTX stock, worth $211,053. This represents 0.02% of its overall portfolio holdings.

Number of Shares
468
Previous 468 -0.0%
Holding current value
$211,053
Previous $219,000 0.91%
% of portfolio
0.02%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 10, 2024

BUY
$343.0 - $410.68 $24,696 - $29,568
72 Added 18.18%
468 $190,000
Q2 2023

Jul 10, 2023

SELL
$314.42 - $351.91 $3,458 - $3,871
-11 Reduced 2.7%
396 $139,000
Q1 2023

Apr 10, 2023

BUY
$283.23 - $323.1 $3,115 - $3,554
11 Added 2.78%
407 $128,000
Q4 2022

Jan 11, 2023

BUY
$285.76 - $321.48 $109,731 - $123,448
384 Added 3200.0%
396 $0
Q3 2022

Oct 18, 2022

BUY
$273.83 - $305.53 $1,095 - $1,222
4 Added 50.0%
12 $3,000
Q1 2022

Apr 11, 2022

BUY
$221.42 - $260.97 $442 - $521
2 Added 33.33%
8 $2,000
Q2 2021

Jul 13, 2021

SELL
$187.49 - $221.1 $937 - $1,105
-5 Reduced 45.45%
6 $1,000
Q1 2021

Apr 14, 2021

BUY
$207.02 - $241.31 $1,035 - $1,206
5 Added 83.33%
11 $2,000
Q4 2020

Jan 11, 2021

SELL
$207.01 - $276.09 $2,691 - $3,589
-13 Reduced 68.42%
6 $1,000
Q3 2020

Oct 08, 2020

BUY
$255.65 - $303.1 $1,533 - $1,818
6 Added 46.15%
19 $5,000
Q2 2020

Jul 13, 2020

BUY
$225.48 - $295.8 $2,931 - $3,845
13 New
13 $4,000
Q1 2019

Apr 04, 2019

SELL
$163.73 - $194.7 $818 - $973
-5 Closed
0 $0
Q3 2018

Oct 03, 2018

BUY
$167.73 - $192.74 $838 - $963
5 New
5 $1,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Sound Income Strategies, LLC Portfolio

Follow Sound Income Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sound Income Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sound Income Strategies, LLC with notifications on news.